CRIS Current Research Information System

VIVARELLI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.758
AS - Asia 3.538
EU - Europa 2.640
AF - Africa 248
SA - Sud America 194
Continente sconosciuto - Info sul continente non disponibili 115
OC - Oceania 2
Totale 11.495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.685
VN - Vietnam 1.062
SG - Singapore 918
CN - Cina 796
GB - Regno Unito 714
IT - Italia 346
SE - Svezia 336
DE - Germania 315
HK - Hong Kong 243
FR - Francia 184
IN - India 178
RU - Federazione Russa 154
UA - Ucraina 142
BR - Brasile 136
NL - Olanda 111
IE - Irlanda 95
BD - Bangladesh 90
TG - Togo 70
ZA - Sudafrica 63
CI - Costa d'Avorio 62
FI - Finlandia 52
EE - Estonia 51
JP - Giappone 51
CA - Canada 43
BG - Bulgaria 32
JO - Giordania 30
KR - Corea 29
SC - Seychelles 28
AR - Argentina 24
PH - Filippine 23
CH - Svizzera 21
BE - Belgio 17
NG - Nigeria 14
PL - Polonia 13
TR - Turchia 13
CO - Colombia 12
ES - Italia 12
GR - Grecia 12
IQ - Iraq 12
TH - Thailandia 12
IR - Iran 11
EC - Ecuador 10
ID - Indonesia 10
PK - Pakistan 10
SA - Arabia Saudita 10
MX - Messico 9
TW - Taiwan 9
HR - Croazia 6
JM - Giamaica 6
UZ - Uzbekistan 5
AL - Albania 4
LB - Libano 4
PY - Paraguay 4
RO - Romania 4
AZ - Azerbaigian 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
MA - Marocco 3
PS - Palestinian Territory 3
PT - Portogallo 3
AT - Austria 2
AU - Australia 2
BY - Bielorussia 2
CL - Cile 2
CY - Cipro 2
DK - Danimarca 2
GT - Guatemala 2
MM - Myanmar 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AW - Aruba 1
BH - Bahrain 1
CM - Camerun 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MY - Malesia 1
NE - Niger 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
SV - El Salvador 1
Totale 11.381
Salva come PNG Salva come JPEG
Città #
Southend 623
Singapore 610
Fairfield 531
Ashburn 496
Dong Ket 305
Chandler 291
Woodbridge 280
San Jose 233
Seattle 232
Hong Kong 225
Wilmington 216
Houston 202
Santa Clara 198
Hanoi 172
Ho Chi Minh City 166
Cambridge 156
Ann Arbor 138
Princeton 126
Council Bluffs 100
Beijing 96
Dublin 95
Jacksonville 90
Boardman 87
Hefei 74
Los Angeles 74
Lomé 70
Dallas 67
Nanjing 66
Abidjan 62
Lauterbourg 60
Padova 60
Westminster 60
New York 46
Tokyo 44
Helsinki 43
Berlin 41
Buffalo 38
Bologna 37
San Diego 37
Jinan 36
Dearborn 34
Shenyang 34
Sofia 32
Amman 30
Munich 28
Milan 27
Saint Petersburg 27
Haiphong 25
Da Nang 24
Florence 24
Seoul 23
Zhengzhou 21
Frankfurt am Main 20
Hebei 20
Shanghai 20
São Paulo 20
Turin 20
Des Moines 19
Guangzhou 19
Nanchang 19
Tianjin 19
Johannesburg 18
Brussels 16
Orem 16
Bern 15
Falkenstein 15
Phoenix 15
The Dalles 15
Abeokuta 14
Jiaxing 14
Toronto 14
Changsha 13
Delhi 13
Hải Dương 13
Monmouth Junction 13
Mülheim 13
London 12
Atlanta 10
Chicago 10
Düsseldorf 10
Hangzhou 10
Mahé 10
Ningbo 10
Norwalk 10
Chennai 9
Verona 9
Baghdad 8
Montreal 8
Mountain View 8
Paris 8
Redondo Beach 8
Thái Bình 8
Yubileyny 8
Lanzhou 7
Leawood 7
Madrid 7
Pune 7
Shenzhen 7
Warsaw 7
Amsterdam 6
Totale 7.509
Salva come PNG Salva come JPEG
Nome #
A new liver transplant priority for patients with hepatocellular carcinoma. 270
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 258
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 254
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 237
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 231
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 228
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 227
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 225
Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG 223
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 219
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 218
Coping strategies in intestinal transplantation 218
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 214
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 213
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 213
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 205
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 205
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 204
Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center 200
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 199
A prospective comparative study between celsior and university of Wisconsin preserving solution in liver transplantation from elderly donors 198
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 197
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 195
Hepatic artery thrombosis and graft ischemia in presence of preserved arterial inflow: not a contradiction but a real possibilty 191
Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. 189
Donor pool expansion in liver transplantation 187
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 180
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 179
ischemic arterial complications following liver transplantation in the adult: multivariate analysis of risk factors 176
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 173
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 172
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. 171
Can Hepatocellular Carcinoma tumor grade and microscopical vascular invasion be predicted with an artificial neural network? 170
Sirolimus in liver transplant recipients: a large single-center experience. 169
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. 168
Liver Transplantation With Left Lateral Segments in Adults: A Risk or a Possibility? 167
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience. 165
Improved detectability of the hepatic arterial tree in liver transplantation by perfusional angiosonography. 163
Comparison between Celsior and UW solutions in liver transplantation from elderly donors 161
Modification of Acid-Base Balance in Cirrhotic Patients Undergoing Liver Resection for Hepatocellular Carcinoma. 160
Alarming correlation between multidrug-resistant bacteriobilia and morbidity after pancreatic surgery 159
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver 158
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. 153
Is portal hypertension a contraindication to hepatic resection? 153
Prediction of significant fibrosis in hepatitis C virus infected liver transplant recipients by artificial neural network analysis of clinical factors. 152
Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? 149
Nested stromal-epithelial tumor (NSET) of the liver: A case report of an extremely rare tumor. 146
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. 145
Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary? 145
Octogenarian livers successfully transplanted in patients with fulminant hepatic failure. 144
Comparison of Celsior and University of Wisconsin solutions in cold preservation of liver from octogenarian donors 142
Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the milan selection criteria. 141
Steroids in intestinal transplantation 140
Surgical approach to complicated intestinal failure for benign disease in adult patients: transplantation or surgical rehabilitation? 135
Twenty-seven consecutive intestinal and multivisceral transplants in adult patients: a 4-year clinical experience. 134
Sirolimus as the main immunosuppressant in the early postoperative period following liver transplantation: a report of six cases and review of the literature. 133
Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. 132
Trends in the characteristics and perioperative outcomes of patients undergoing laparoscopic and open resections for benign liver lesions: An international multicenter retrospective cohort study of 845 patients 130
Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. 125
Successful arterial revascularization in liver transplantation using a cryopreserved arterial allograft. 122
Effect of total enterectomy, pancreatectomy, and portal vein ligation on liver function and histology: a case report. 118
Tecnica chirurgica del trapianto di fegato 93
Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: Correlation with antigenemia 87
Influence of steroids on HCV recurrence after liver transplantation: A prospective study. 87
Abstension from treatment of low-level pp65 cytomegalovirus antigenemia after liver transplantation: A prospective study 74
Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression? 71
Simultaneous presence of focal nodular hyperplasia and hepatocellular carcinoma: Case report and review of the literature 69
Stratifying the risk in liver surgery: performance in an Italian cohort of 3.280 liver resection for HCC 62
Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence 2
Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. 2
Totale 11.495
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.763
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.002 0 0 91 95 109 60 25 72 33 65 279 173
2022/20231.279 122 225 75 150 70 104 35 64 239 30 110 55
2023/2024331 31 64 18 26 29 69 16 23 11 22 12 10
2024/20251.553 77 240 114 132 274 69 97 32 9 140 40 329
2025/20263.087 251 209 327 185 342 218 284 98 638 246 156 133
2026/2027373 52 119 202 0 0 0 0 0 0 0 0 0
Totale 11.495